Europe Bacteriological Testing Market By Product (Instruments, Test Kits, Consumable Reagents); By Bacteria (Salmonella, Coliform, Listeria, Legionella, Campylobacter, Others); By Technology (Traditional, Rapid); By End User (Food & Beverage, Pharmaceutical, Cosmetics & Personal Care, Water, Others); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Europe Bacteriological Testing Market size was valued at USD 3,659.94 million in 2018, rising to USD 5,375.66 million in 2024, and is anticipated to reach USD 9,367.70 million by 2032, at a CAGR of 7.19% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Europe Bacteriological Testing Market Size 2024
USD 5,375.66 Million
Europe Bacteriological Testing Market, CAGR
7.19%
Europe Bacteriological Testing Market Size 2032
USD 9,367.70 Million
The Europe Bacteriological Testing Market is shaped by the presence of global leaders and regional specialists offering diverse testing solutions. Major players such as Merieux NutriSciences, Thermo Fisher Scientific Inc., Eurofins, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Intertek, Merck KGaA, Neogen Corporation, BioMerieux, Symbio Labs, Alfa Chemistry, and Vimta Labs strengthen their positions through advanced instruments, rapid test kits, and compliance-driven services. These companies focus on innovation, automation, and strategic collaborations to expand their reach across industries, including food, pharmaceuticals, and water testing. Germany emerges as the leading region with a 24% market share in 2024, supported by its strong food processing base, advanced laboratory infrastructure, and strict regulatory enforcement driving demand for bacteriological testing solutions.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Europe Bacteriological Testing Market was USD 3,659.94 million in 2018, reached USD 5,375.66 million in 2024, and is projected at USD 9,367.70 million by 2032, growing at 7.19%.
Instruments dominate by product with 42% share in 2024, supported by automation demand, while test kits hold 34% and consumable reagents account for 24%.
Salmonella leads by bacteria with 30% share, followed by coliform at 25% and Listeria at 18%, with Legionella, Campylobacter, and others comprising the rest.
Rapid testing holds 63% share in 2024, driven by speed, accuracy, and compliance, while traditional testing accounts for 37% within regulated labs and research centers.
Germany leads regionally with 24% share, followed by the U.K. at 17% and France at 15%, while Italy, Spain, Russia, and the Rest of Europe collectively strengthen the market.
Market Segment Insights
By Product
Instruments hold the largest share of the Europe Bacteriological Testing Market, accounting for 42% of revenue in 2024. Their dominance is supported by growing demand for advanced analytical equipment, automation in laboratories, and higher accuracy requirements across food and pharmaceutical testing. Test kits represent around 34% share, driven by rising adoption in rapid detection processes, particularly in field testing and smaller laboratories. Consumable reagents capture 24%, reflecting steady demand as recurring supplies in routine bacteriological testing workflows.
For instance, Thermo Fisher Scientific launched the SureTect Listeria monocytogenes PCR Assay, expanding its portfolio of validated molecular detection kits for food safety testing.
By Bacteria
Salmonella leads the segment with a 30% market share in 2024, as regulatory agencies and industries focus on controlling foodborne pathogens. Coliform testing follows with 25%, due to its critical role in water and beverage safety monitoring. Listeria accounts for 18%, supported by stringent guidelines in dairy and ready-to-eat food industries. Legionella represents 12%, as Europe enforces strict monitoring in water systems and healthcare facilities. Campylobacter holds 10%, while others collectively contribute 5%, covering broader pathogen surveillance needs.
For instance, Bio-Rad Laboratories launched its iQ-Check Salmonella II PCR kit in Europe, validated under ISO 16140-2 for improved detection in food samples.
By Technology
Rapid testing dominates the technology segment with 63% share in 2024, fueled by demand for faster turnaround, improved accuracy, and compliance with stringent food safety standards. The adoption of rapid methods is rising across food, water, and pharmaceutical industries, driven by the need for real-time detection. Traditional methods maintain a 37% share, as they remain standard in regulated laboratories and research institutions where detailed analysis and validation are required.
Key Growth Drivers
Rising Food Safety Regulations
Stringent food safety regulations across Europe remain a major driver for the bacteriological testing market. Agencies such as EFSA and national regulators enforce strict monitoring of foodborne pathogens like Salmonella and Listeria. This regulatory pressure compels food producers and processors to adopt advanced testing solutions. Growing consumer awareness about contamination risks further boosts compliance-driven testing. As a result, both large and mid-scale manufacturers increase investments in routine bacteriological testing, ensuring consistent demand for instruments, test kits, and reagents across the region.
For instance, Eurofins Scientific launched a new Listeria Whole Genome Sequencing (WGS) service in Germany to help food companies meet EFSA’s stricter monitoring requirements for pathogen tracing.
Expanding Pharmaceutical and Healthcare Applications
The pharmaceutical sector contributes significantly to market growth by requiring bacteriological testing to ensure drug safety and sterility. Rising production of biologics, injectable drugs, and vaccines drives demand for accurate microbial contamination detection methods. Healthcare institutions also prioritize water and environmental monitoring to prevent hospital-acquired infections. With Europe’s strong pharmaceutical base, particularly in Germany, Switzerland, and the UK, investments in microbiological quality control continue to rise. This broader application spectrum strengthens market adoption of both traditional and rapid bacteriological testing technologies.
For instance, Merck KGaA launched the Milliflex® Rapid System 2.0, a rapid automated solution for microbial testing in pharmaceuticals, helping companies reduce sterility testing time from 14 days to less than 5 days.
Technological Advancements in Rapid Testing
Advancements in rapid testing technologies drive market expansion by improving speed, sensitivity, and ease of use. Techniques such as PCR, immunoassays, and biosensors are increasingly adopted to deliver real-time results, helping industries reduce downtime and product recalls. Automation in sample preparation and analysis also improves efficiency in high-volume testing labs. In addition, growing R&D investments from key players enhance product availability and innovation. These technological improvements align with industry needs for reliable, cost-effective, and regulatory-compliant bacteriological testing solutions across Europe’s food, pharma, and water sectors.
Key Trends & Opportunities
Adoption of Digital and Automated Solutions
Automation and digitalization are emerging as strong trends in Europe’s bacteriological testing market. Automated sample handling and advanced data analytics reduce human error while increasing throughput. Integration of AI-based platforms with laboratory information management systems (LIMS) is creating opportunities for faster decision-making and predictive contamination control. The shift toward smart laboratories supports compliance with strict quality standards and offers cost savings. These advancements create a long-term opportunity for testing service providers and technology developers to expand across Europe’s industrial and healthcare sectors.
For instance, bioMérieux launched the MAST ISOPLEX® Bacteria Detect, an automated molecular test platform in Europe designed to accelerate pathogen identification in food and clinical labs, supporting digital workflows for faster results.
Growing Demand for Environmental and Water Testing
The rising focus on environmental safety and water quality monitoring creates fresh opportunities for bacteriological testing in Europe. Governments and municipalities are enforcing strict monitoring of Legionella and coliform bacteria to reduce risks in public water supplies. Industries such as hospitality and healthcare are increasing investment in water testing solutions to ensure safety and compliance. With climate change influencing microbial growth in water systems, demand for reliable and rapid testing is expected to accelerate. This trend offers significant expansion prospects for technology providers and testing laboratories.
For instance, IDEXX Laboratories launched the Legionella EZ Test in Europe, a culture-based detection method designed to provide results in seven days, supporting compliance with EU and national guidelines.
Key Challenges
High Cost of Advanced Testing Technologies
The cost of advanced bacteriological testing technologies remains a barrier to wider adoption, especially among small and medium enterprises. Instruments, automated systems, and molecular testing kits involve high upfront investments and recurring expenses. Smaller food processors and water testing labs often rely on traditional methods due to budget constraints. This cost challenge limits penetration of rapid technologies in some segments, slowing overall market growth. Addressing affordability through cost-effective solutions and partnerships remains a key challenge for market players in Europe.
Regulatory Complexity Across Countries
Regulatory frameworks for bacteriological testing vary across European countries, creating compliance challenges for businesses. While EU-level agencies provide overarching guidelines, each member state enforces its own standards and testing requirements. Companies operating in multiple countries face increased costs and operational complexity to align with diverse rules. Inconsistencies in approval timelines and certification processes also delay the adoption of new technologies. This fragmented regulatory environment adds uncertainty for industry participants and hinders the smooth expansion of bacteriological testing practices across Europe.
Skilled Workforce Shortages
A shortage of skilled professionals in microbiology and laboratory testing poses a challenge for the bacteriological testing market. Operating advanced instruments and interpreting rapid test results require specialized expertise, which many smaller labs struggle to maintain. The growing reliance on automation and digital systems further increases the need for technically trained staff. Without adequate workforce development, laboratories face delays and errors in testing processes. This talent gap may restrict the efficient implementation of advanced testing solutions across industries in Europe.
Regional Analysis
Germany
Germany leads the Europe Bacteriological Testing Market with a 24% share in 2024. Strong presence of food and beverage processing industries drives consistent demand for bacteriological testing. The country enforces strict food safety regulations, particularly for Salmonella and Listeria control, which supports the adoption of advanced testing technologies. Pharmaceutical and healthcare sectors also contribute to market growth through high investment in microbial quality control. Germany’s well-established laboratory infrastructure enables rapid adoption of automation and molecular testing. It remains a key hub for technological innovation and market expansion.
U.K.
The U.K. holds a 17% share in the Europe Bacteriological Testing Market. Growing consumer awareness and strict oversight from the Food Standards Agency encourage widespread adoption of bacteriological testing solutions. The market benefits from increasing demand in water quality monitoring, driven by Legionella control regulations. The country’s strong healthcare and pharmaceutical base ensures continuous use of rapid testing systems. Investments in R&D strengthen opportunities for automation and advanced diagnostic methods. It continues to expand due to demand from both industrial and public health sectors.
France
France accounts for 15% of the Europe Bacteriological Testing Market. Its strong dairy and meat processing sectors generate steady demand for bacteriological testing across the supply chain. Regulatory emphasis on foodborne pathogens such as Listeria and Salmonella supports the widespread adoption of both traditional and rapid testing methods. Pharmaceutical manufacturing and healthcare institutions also contribute to market revenues. Local laboratories increasingly adopt advanced kits and reagents for high-volume testing. It remains an important contributor to regional market growth with ongoing investments in testing infrastructure.
Italy
Italy captures a 12% share in the Europe Bacteriological Testing Market. The market is supported by demand from food and beverage exports, particularly in dairy and meat products, which require extensive microbial testing. National regulations aligned with EU standards drive the adoption of both rapid and traditional technologies. Water safety monitoring also creates additional demand, especially for Legionella detection. Increasing modernization of laboratories enhances the uptake of automated instruments. It continues to strengthen its position with growing reliance on bacteriological testing in export-driven sectors.
Spain
Spain holds a 10% share in the Europe Bacteriological Testing Market. The food industry’s focus on seafood and meat processing creates significant demand for microbial safety testing. National enforcement of hygiene regulations ensures routine bacteriological testing across food facilities. Pharmaceutical and cosmetics industries also use advanced methods to ensure product safety. Rapid urbanization and tourism further push the demand for water quality monitoring. It remains an expanding market segment with rising adoption of cost-effective rapid testing solutions.
Russia
Russia accounts for 9% of the Europe Bacteriological Testing Market. Demand is driven by stricter enforcement of food safety standards and growing awareness of microbial contamination risks. Local industries increasingly adopt rapid technologies, supported by international partnerships and equipment imports. Pharmaceutical and healthcare applications also expand, requiring consistent bacteriological monitoring. Investments in laboratory modernization support the adoption of advanced instruments. It demonstrates steady growth with rising demand for comprehensive testing solutions across multiple sectors.
Rest of Europe
The Rest of Europe contributes 13% to the Europe Bacteriological Testing Market. Countries in Eastern and Northern Europe are expanding their testing capacities with support from EU-funded food safety programs. The demand for bacteriological testing grows in food exports, water management, and healthcare services. Increasing focus on compliance with EU guidelines encourages broader adoption of advanced testing technologies. Local laboratories gradually integrate rapid testing methods to meet regulatory standards. It strengthens overall regional demand by bridging gaps in testing infrastructure across smaller markets.
Market Segmentations:
By Product
Instruments
Test Kits
Consumable Reagents
By Bacteria
Salmonella
Coliform
Listeria
Legionella
Campylobacter
Others
By Technology
Traditional
Rapid
By End User
Food and Beverage
Pharmaceutical
Cosmetics & Personal Care
Water
Others
By Region
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Competitive Landscape
The competitive landscape of the Europe Bacteriological Testing Market is defined by the presence of global leaders and specialized regional players offering a wide portfolio of instruments, test kits, and reagents. Companies such as Merieux NutriSciences, Thermo Fisher Scientific, Eurofins, and Agilent Technologies maintain strong positions through advanced technologies and extensive laboratory networks. Bio-Rad Laboratories, Merck KGaA, and BioMerieux focus on innovation in rapid testing solutions, supported by continuous R&D investments. Intertek and Neogen Corporation strengthen their reach through compliance-driven testing services across food, pharmaceutical, and water industries. Emerging participants such as Vimta Labs, Symbio Labs, and Alfa Chemistry contribute to competitive diversity by offering specialized solutions and localized expertise. The market remains competitive with frequent product launches, strategic collaborations, and acquisitions aimed at expanding service capabilities and geographic reach. It reflects a balanced mix of multinational corporations and niche providers, fostering innovation and ensuring broad coverage across industries.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In September 2025, Sysmex Europe entered into a strategic partnership with Kuehne+Nagel to enhance distribution and healthcare sector operations in Europe for bacteriological and related testing solutions.
In September 2025, LuminUltra acquired France-based GL Biocontrol to strengthen its microbial testing presence in Europe.
In February 2025, bioMérieux launched GENE-UP® TY per, a PCR solution to accelerate Listeria monocytogenes root cause analysis in the food sector.
Report Coverage
The research report offers an in-depth analysis based on Product, Bacteria, Technology, End User and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Demand for bacteriological testing will grow with stricter European food safety regulations.
Rapid testing technologies will gain wider adoption across food, pharma, and water sectors.
Automation and digital integration will enhance efficiency in laboratory operations.
Pharmaceutical manufacturing will drive steady demand for microbial contamination testing.
Water testing for Legionella and coliform bacteria will expand with public safety initiatives.
Advanced test kits will become more common in small and mid-sized laboratories.
Environmental monitoring will emerge as a key area of application for testing solutions.
Regional laboratories will modernize infrastructure to meet EU compliance standards.
Strategic partnerships and acquisitions will strengthen market presence of leading players.
Growing consumer awareness of hygiene will sustain investment in bacteriological testing solutions.
CHAPTER NO. 1 : GENESIS OF THE MARKET
1.1 Market Prelude – Introduction & Scope
1.2 The Big Picture – Objectives & Vision
1.3 Strategic Edge – Unique Value Proposition
1.4 Stakeholder Compass – Key Beneficiaries CHAPTER NO. 2 : EXECUTIVE LENS
2.1 Pulse of the Industry – Market Snapshot
2.2 Growth Arc – Revenue Projections (USD Million)
2.3. Premium Insights – Based on Primary Interviews CHAPTER NO. 3 : BACTERIOLOGICAL TESTING MARKET FORCES & INDUSTRY PULSE
3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown CHAPTER NO. 4 : KEY INVESTMENT EPICENTER
4.1 Regional Goldmines – High-Growth Geographies
4.2 Product Frontiers – Lucrative Product Categories
4.3 Technology Sweet Spots – Emerging Demand Segments CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING
5.1 Momentum Metrics – Forecast & Growth Curves
5.2 Regional Revenue Footprint – Market Share Insights
5.3 Segmental Wealth Flow – Product, Bacteria, Technology, & End User Revenue CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS
6.1. Import Analysis By Region
6.1.1. Europe Bacteriological Testing Market Import Revenue By Region
6.2. Export Analysis By Region
6.2.1. Europe Bacteriological Testing Market Export Revenue By Region CHAPTER NO. 7 : COMPETITION ANALYSIS
7.1. Company Market Share Analysis
7.1.1. Europe Bacteriological Testing Market: Company Market Share
7.2. Europe Bacteriological Testing Market Company Revenue Market Share
7.3. Strategic Developments
7.3.1. Acquisitions & Mergers
7.3.2. New Product Launch
7.3.3. Regional Expansion
7.4. Competitive Dashboard
7.5. Company Assessment Metrics, 2024 CHAPTER NO. 8 : BACTERIOLOGICAL TESTING MARKET – BY PRODUCT SEGMENT ANALYSIS
8.1. Bacteriological Testing Market Overview By Product Segment
8.1.1. Bacteriological Testing Market Revenue Share By Product
8.2. Instruments
8.3. Test Kits
8.4. Consumable Reagents CHAPTER NO. 9 : BACTERIOLOGICAL TESTING MARKET – BY BACTERIA SEGMENT ANALYSIS
9.1. Bacteriological Testing Market Overview By Bacteria Segment
9.1.1. Bacteriological Testing Market Revenue Share By Bacteria
9.2. Salmonella
9.3. Coliform
9.4. Listeria
9.5. Legionella
9.6. Campylobacter
9.7. Others CHAPTER NO. 10 : BACTERIOLOGICAL TESTING MARKET – BY TECHNOLOGY SEGMENT ANALYSIS
10.1. Bacteriological Testing Market Overview By Technology Segment
10.1.1. Bacteriological Testing Market Revenue Share By Technology
10.2. Traditional
10.3. Rapid CHAPTER NO. 11 : BACTERIOLOGICAL TESTING MARKET – BY END USER SEGMENT ANALYSIS
11.1. Bacteriological Testing Market Overview By End User Segment
11.1.1. Bacteriological Testing Market Revenue Share By End User
11.2. Food and Beverage
11.3. Pharmaceutical
11.4. Cosmetics & Personal Care
11.5. Water
11.6. Others CHAPTER NO. 12 : EUROPE BACTERIOLOGICAL TESTING MARKET – COUNTRY ANALYSIS
12.1. Europe Bacteriological Testing Market Overview By Country Segment
12.1.1. Europe Bacteriological Testing Market Revenue Share By Region
12.2. Europe
12.2.1. Europe Bacteriological Testing Market Revenue By Country
12.2.2. Product
12.2.3. Europe Bacteriological Testing Market Revenue By Product
12.2.4. Bacteria
12.2.5. Europe Bacteriological Testing Market Revenue By Bacteria
12.2.6. Technology
12.2.7. Europe Bacteriological Testing Market Revenue By Technology
12.2.8. End User
12.2.9. Europe Bacteriological Testing Market Revenue By End User
12.3. Germany
12.4. U.K.
12.5. France
12.6. Italy
12.7. Spain
12.8. Russia
12.9. Rest of Europe CHAPTER NO. 13 : COMPANY PROFILES
13.1. Merieux NutriSciences Corporation
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.3. Financial Overview
13.1.4. Recent Developments
13.1.5. Growth Strategy
13.1.6. SWOT Analysis
13.2. Thermo Fisher Scientific Inc.
13.3. Eurofins
13.4. Agilent Technologies Inc.
13.5. Bio-Rad Laboratories Inc.
13.6. Intertek
13.7. Merck kGaA
13.8. Neogen Corporation
13.9. Vimta Labs
13.10. BioMerieux
13.11. Symbio Labs
13.12. Alfa Chemistry
13.13. Other Key Players
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for Europe Bacteriological Testing Market, and what is its projected size in 2032?
The Europe Bacteriological Testing Market reached USD 5,375.66 million in 2024 and is projected to reach USD 9,367.70 million by 2032, showing strong growth.
At what Compound Annual Growth Rate is the Europe Bacteriological Testing Market projected to grow between 2025 and 2032?
The Europe Bacteriological Testing Market is projected to expand at a Compound Annual Growth Rate (CAGR) of 7.19% between 2025 and 2032, reflecting sustained industry demand.
Which Europe Bacteriological Testing Market segment held the largest share in 2024?
In 2024, instruments held the largest share of the Europe Bacteriological Testing Market with 42%, driven by automation, accuracy requirements, and strong laboratory adoption.
What are the primary factors fueling the growth of the Europe Bacteriological Testing Market?
Key factors driving growth include rising food safety regulations, expanding pharmaceutical and healthcare applications, and technological advancements in rapid testing supporting faster, reliable, and compliant detection.
Who are the leading companies in the Europe Bacteriological Testing Market?
Leading companies include Merieux NutriSciences, Thermo Fisher Scientific, Eurofins, Agilent Technologies, Bio-Rad Laboratories, Merck KGaA, Intertek, Neogen, BioMerieux, Symbio Labs, Alfa Chemistry, and others.
Which region commanded the largest share of the Europe Bacteriological Testing Market in 2024?
Germany commanded the largest share of the Europe Bacteriological Testing Market in 2024 with 24%, supported by strong food, pharmaceutical, and healthcare sector demand.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The Recombinant Protein Market is projected to experience substantial growth, with its value expected to surge from USD 1,897.70 million in 2023 to USD 4,577.70 million by 2032, reflecting a robust CAGR of 10%.
The bio-based isoprene market size was valued at USD 1.13 billion in 2024 and is anticipated to reach USD 1.71 billion by 2032, at a CAGR of 5.3% during the forecast period.
The UK Occupational Health Market is projected to grow from USD 2,204.85 million in 2024 to an estimated USD 3,773.55 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.47% from 2024 to 2032.
North America Cell-Free Protein Synthesis Reagents Market size was valued at USD 93.22 million in 2018 to USD 157.49 million in 2024 and is anticipated to reach USD 292.22 million by 2032, at a CAGR of 7.5% during the forecast period.
Cell-Free Protein Synthesis Reagents Market size was valued at USD 211.27 million in 2018 to USD 360.63 million in 2024 and is anticipated to reach USD 667.31 million by 2032, at a CAGR of 7.45% during the forecast period.
The Global Diclofenac Diethylamine Market size was valued at USD 3,761.29 million in 2018 to USD 7,022.44 million in 2024 and is anticipated to reach USD 18,908.01 million by 2032, at a CAGR of 12.28% during the forecast period.
The Histology and Cytology Market size was valued at USD 13,200.0 million in 2018 to USD 21,540.1 million in 2024 and is anticipated to reach USD 67,086.1 million by 2032, at a CAGR of 15.3% during the forecast period.
The Global Unnatural Amino Acid Market size was valued at USD 4,700.0 million in 2018 to USD 6,718.0 million in 2024 and is anticipated to reach USD 14,798.5 million by 2032, at a CAGR of 10.5% during the forecast period.
The Hematopoietic Stem Cell Transplantation market size was valued at USD 3240 million in 2024 and is expected to reach USD 7740.1 million by 2032, growing at a CAGR of 11.5% during the forecast period.
The Magnetic Beads Market was valued at USD 3.49 billion in 2024 and is projected to reach USD 8.16 billion by 2032, growing at a CAGR of 11.2% during the forecast period.
The Cryo-Em Structure Analysis Services Market size was valued at USD 695.37 million in 2018 to USD 1,215.00 million in 2024 and is anticipated to reach USD 2,677.34 million by 2032, at a CAGR of 9.67% during the forecast period.
The NGS (Next-Generation Sequencing) Sample Preparation Market was valued at USD 1,412.5 million in 2024 and is projected to reach USD 2,793.9 million by 2032, expanding at a CAGR of 8.9% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
